Joshua Schrecker

Statistics

Publications

Citations

115

H-Index

Active since

2018

Affiliations

AEgis Technologies (United States)(Current)

Walgreens (United States)

University of California, San Francisco

Deerfield (United States)

University of California, Los Angeles

Joshua Schrecker is an author at AEgis Technologies (United States) specializing in drug - drug interaction management, pharmacology, and clinical pharmacology.

ORCID

Publications per year

2018–2022

Publications

Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age

Farid Khan, Jennifer L. Nguyen, Tanya Singh et al. · JAMA Network Open · 2022 · 41 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Drug-Drug Interaction Assessment and Identification in the Primary Care Setting

John Peabody, Maria Czarina Acelajado, Tim Robert et al. · Journal of Clinical Medicine Research · 2018 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variants

Cyndi Clark, Joshua Schrecker, Matthew Hardison et al. · PLoS ONE · 2022 · 19 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care

Renée J.G. Arnold, Jun Tang, Joshua Schrecker et al. · Drugs - Real World Outcomes · 2018 · 17 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +11

Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results

John Peabody, Joshua Schrecker, Rebecca Heltsley et al. · Diagnostics · 2021 · 10 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

1–5 of 5